Vetter adds 10 filling lines to expand global manufacturing network

Vetter is expanding its commercial fill-and-finish network with 10 additional filling lines across existing sites and a new site in Saarlouis, Germany, to support injectable drug customers. The phased buildout is aimed at adding capacity, resilience and service capabilities through 2031.

Why it matters: - Vetter is increasing capacity for injectable therapies as pharma and biotech companies look for partners that can support current products and future pipelines. - The expansion is meant to strengthen manufacturing resilience, supply-chain stability and long-term service capabilities across international markets.

What happened: - Vetter is adding 10 commercial filling lines as part of a long-term investment program. - Seven of the 10 lines are being installed at Vetter’s existing sites. - The first new line, built to fill pre-sterilized syringes, recently became operational. - A second line is expected to go live by the end of 2026. - Five additional aseptic production lines are planned through 2028. - The final three lines are planned for Vetter’s new commercial site in Saarlouis, Germany, which is expected to become operational by 2031.

The details: - Vetter is also expanding compounding, pharmaceutical storage and visual inspection capabilities. - The company is adding advanced cleanroom technology. - Vetter is increasing automation and digitalization across operations. - Managing Director Henryk Badack said the investment strategy is designed to support customers throughout the lifecycle of their products in international markets. - Managing Director Carsten Press said the phased approach is intended to add capacity while expanding Vetter’s global production network.

Between the lines: - The buildout signals that Vetter is betting on sustained demand for aseptic fill-finish services rather than short-term growth. - The mix of near-term upgrades at existing sites and a later greenfield site in Saarlouis suggests the company is balancing immediate capacity needs with longer-term network planning. - More automation and digitalization can also help standardize quality and improve throughput in a tightly regulated manufacturing process.

What's next: - Vetter expects more manufacturing resources to come online over the coming years as the phased rollout continues. - The company will present its current and future project requirements at CPHI Milan from October 6 to 8, 2026, at booth 6A52. - Vetter also shared its LinkedIn updates for stakeholders following the expansion.

The bottom line: - Vetter is scaling its global fill-and-finish footprint now to give pharma and biotech customers more capacity, flexibility and supply resilience later.